301207

Hualan Biological Vaccine
301207

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥12.55B
EV
CN¥9.48B
Shares Outstanding
595.00M
Beta
0.84
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
2
P/E 2025E
15.24x
P/Revenue 2025E
7.19x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Hualan Biological Vaccine Inc.

gainify
301207

Hualan Biological Vaccine Inc.

301207

Hualan Biological Vaccine Inc. engages in the research, development, production, and sale of vaccines in China. It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, influenza A (H1N1) virus split vaccines, ACYW135 group meningococcal ...

Sector

Healthcare

Industry

Biotechnology

CEO

An, Wenjue

Employees

748

IPO Date

2022-02-18

Headquarters

Jia No. 1-1, Hualan Avenue, Xinxiang, Henan Province, 453003, China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.